Abiopharma

🔍 Allen Herbert A III (Director)

Company: COCA COLA CO (KO)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock, $.25 Par Value (Direct)
  Date: 2026-04-01 | Code: H | shares_owned_after: 162,610.00 | Footnotes: F1
• Holds 0 shares of Common Stock, $.25 Par Value (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: Allen & Company LLC | shares_owned_after: 99,054.00 | Footnotes: F2
• Acquired 4,089 shares of Phantom Share Units (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 22,601.90 | transaction_form_type: 4 | Footnotes: F3, F4, F5, F5, F6

Footnotes:

• F1: Exhibit Index - Exhibit No. 24 - Power of Attorney
• F2: Shares owned by Allen & Company LLC, of which the reporting person is the President. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
• F3: Each phantom share unit is economically equivalent to one share of Common Stock.
• F4: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective June 1, 2025 (the "Directors' Plan") for 2026 compensation, which may include voluntary deferred compensation.
• F5: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.
• F6: This number includes phantom share units accrued through April 1, 2026 under the Directors' Plan as a result of crediting phantom dividends.